Table 1 Percent of inhibition of inflammation, endothelial activation, NF-κB and eNOS biomarkers by each FD variety based on area under the curve (AUC) analysis
VCAM-1% inhibition | ICAM-1% inhibition | E-selectin % inhibition | IL-6% inhibition | NF-κB p50% inhibition | NF-κB p65% inhibition | eNOS % increment | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P | G | P | G | P | G | P | G | P (N) | P (C) | G | P (N) | P (C) | G | P | G | |
FDT | 59.4 | 77.7 | 33.8 | 8.1 | 75.4 | 76.5 | 66.0 | 69.2 | 6.4 | 10.3 | 85.3 | 39.4 | 10.4 | 200.9 | 15.7 | −100.1 |
FDK | 52.8 | 82.0 | 24.5 | 22.1 | 74.3 | 75.2 | 65.5 | 67.3 | 5.1 | 10.3 | 87.6 | 34.9 | 16.8 | 330.8 | 15.1 | −100.0 |
FDD | 38.8 | 46.3 | 18.1 | −8.2 | 56.3 | 27.3 | 31.5 | 39.1 | 10.0 | 12.6 | 72.1 | 7.6 | 19.5 | 1046.1 | −4.8 | −99.1 |
FDI | 4.7 | 53.5 | 10.5 | 10.8 | 49.7 | 74.9 | 25.3 | 60.9 | 4.3 | 8.0 | 82.8 | 11.1 | 12.4 | 103.8 | 2.6 | −100.1 |